TY - JOUR
KW - Abnormalities, Drug-Induced
KW - Analgesics, Opioid/adverse effects
KW - Female
KW - Humans
KW - Methadone/adverse effects
KW - Morphine Derivatives/adverse effects
KW - Opioid-Related Disorders/drug therapy
KW - Pregnancy
KW - Pregnancy Complications/drug therapy
KW - Research Design
AU - Jennifer N. Lind
AU - Julia D. Interrante
AU - Elizabeth C. Ailes
AU - Suzanne M. Gilboa
AU - Sara Khan
AU - Meghan T. Frey
AU - April L. Dawson
AU - Margaret A. Honein
AU - Nicole F. Dowling
AU - Hilda Razzaghi
AU - Andreea A. Creanga
AU - Cheryl S. Broussard
A1 - 
AD - Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia; jlind@cdc.gov.; US Public Health Service, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.; Carter Consulting, Atlanta, Georgia; and.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Congenital and Developmental Disorders, National Center on Birth D(TRUNCATED)
BT - Pediatrics
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 6
CY - United States
DO - 10.1542/peds.2016-4131
IS - 6
JF - Pediatrics
LA - eng
M1 - Journal Article
PB - by the American Academy of Pediatrics
PP - United States
PY - 2017
SN - 1098-4275; 0031-4005
SP - 10.1542/peds.2016
EP - 4131
EP - 
T1 - Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
T2 - Pediatrics
TI - Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28562278
U3 - 10.1542/peds.2016-4131
VL - 139
VO - 1098-4275; 0031-4005
Y1 - 2017
Y2 - Jun
ER -